Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A Develops oligonucleotide therapeutics targeting chronic hepatitis B | $120M | Series CSeries C+ | Biotech | United States | Investors |
Ranked by rounds participated in · From Jan 1, 2026
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
| PT ProFound TherapeuticsCompany profile Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia | $35M | StrategicUndisclosed | Biotech | United States | Investors |
| T TransfyrCompany profile Physical AI platform capturing real-world lab science into machine-readable data Physical AI platform capturing real-world lab science into machine-readable data | $25M | Seed | Biotech | United States | Investors |
| AT Airway TherapeuticsCompany profile Develops biologic therapies for respiratory and infectious diseases Develops biologic therapies for respiratory and infectious diseases | $50M | Series E2Series C+ | Biotech | United States | Investors |
| O OmicsBankCompany profile Connects fragmented hospital data for drug development and healthcare AI research Connects fragmented hospital data for drug development and healthcare AI research | $2.3M | Seed | Biotech, Healthtech | United States | Investors |
| PT Pixelgen TechnologiesCompany profile High-throughput platform mapping molecular cell architecture at nanoscale resolution High-throughput platform mapping molecular cell architecture at nanoscale resolution | $15.5M | Series B | Biotech | Sweden | Investors |
| KI KaliVir ImmunotherapeuticsCompany profile Develops oncolytic immunotherapies for patients with advanced solid tumors Develops oncolytic immunotherapies for patients with advanced solid tumors | $14M | Series A | Biotech | United States | Investors |
| NB Network BioCompany profile Builds AI models trained on patient tissue and clinical data for disease diagnostics Builds AI models trained on patient tissue and clinical data for disease diagnostics | $50M | StrategicUndisclosed | Biotech | United States | Investors |
| A AuraGxPCompany profile AI-native SaaS platform connecting quality, procurement and vendor management for life sciences AI-native SaaS platform connecting quality, procurement and vendor management for life sciences | Undisclosed | Seed | Biotech | United States | Investors Undisclosed |
| C ComputomicsCompany profile Machine learning platform predicting crop variety performance for climate-smart breeding Machine learning platform predicting crop variety performance for climate-smart breeding | €6.3M | Series B | Biotech, Agritech | Germany | Investors |